Nutrigenomics Market By Product, Techniques And Application- Global Industry Analysis And Forecast To 2023

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Nutrigenomics Market, By Product

5.1.       Introduction

5.2.       Global Nutrigenomics Sales, Revenue and Market Share by Product (2017-2027)

5.2.1.  Global Nutrigenomics Sales and Sales Share by Product (2017-2027)

5.2.2.  Global Nutrigenomics Revenue and Revenue Share by Product (2017-2027)

5.3.       Reagents & Kits

5.3.1.  Global External Sales and Growth Rate (2017-2027)

5.4.       Services

5.4.1.  Global Internal Sales and Growth Rate (2017-2027)

6.       Nutrigenomics Market, By Technique

6.1.       Introduction

6.2.       Global Nutrigenomics Sales, Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Nutrigenomics Sales and Sales Share by Application (2017-2027)

6.2.2.  Global Nutrigenomics Revenue and Revenue Share by Application (2017-2027)

6.3.    Saliva

6.3.1.  Global Saliva Sales and Growth Rate (2017-2027)

6.4.    Buccal Swab

6.4.1.  Global Buccal Swab Sales and Growth Rate (2017-2027)

6.5.       Blood

6.5.1.  Global Blood Sales and Growth Rate (2017-2027)

6.6.       Other Techniques

6.6.1.  Global Other Techniques Sales and Growth Rate (2017-2027)

7.       Nutrigenomics Market, By Application

7.1.       Introduction

7.2.       Global Nutrigenomics Sales, Revenue and Market Share by Techniques (2017-2027)

7.2.1.  Global Nutrigenomics Sales and Sales Share by Techniques (2017-2027)

7.2.2.  Global Nutrigenomics Revenue and Revenue Share by Techniques (2017-2027)

7.3.   Obesity

7.3.1.  Global Obesity Sales and Growth Rate (2017-2027)

7.4.       Diabetes

7.4.1.  Global Diabetes Sales and Growth Rate (2017-2027)

7.5.       Anti-Aging

7.5.1.  Global  Anti-Aging Sales and Growth Rate (2017-2027)

7.6.       Chronic Diseases

7.6.1.  Global Chronic Diseases Sales and Growth Rate (2017-2027)

8.       Nutrigenomics Market, By Region

8.1.       Introduction

8.2.       Global Nutrigenomics Sales, Revenue and Market Share by Regions

8.2.1.  Global Nutrigenomics Sales by Regions (2017-2027)

8.2.2.  Global Nutrigenomics Revenue by Regions (2017-2027)

8.3.       North America Nutrigenomics by Countries

8.3.1.  North America Nutrigenomics Sales and Growth Rate (2017-2027)

8.3.2.  North America Nutrigenomics Revenue and Growth Rate (2017-2027)

8.3.3.  North America Nutrigenomics Sales by Countries (2017-2027)

8.3.4.  North America Nutrigenomics Revenue (Million USD) by Countries (2017-2027)

8.3.5.  U.S.

8.3.5.1.    United States Nutrigenomics Sales and Growth Rate (2017-2027)

8.3.5.2.    United States Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.6.  Canada

8.3.6.1.    Canada Nutrigenomics Sales and Growth Rate (2017-2027)

8.3.6.2.    Canada Nutrigenomics Sales (Millions USD) and Growth Rate (2017-2027)

8.3.7.  Mexico

8.3.7.1.    Mexico Nutrigenomics Sales and Growth Rate (2017-2027)

8.3.7.2.    Mexico Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.       Europe Nutrigenomics by Countries

8.4.1.  Europe Nutrigenomics Sales and Growth Rate (2017-2027)

8.4.2.  Europe Nutrigenomics Revenue and Growth Rate (2017-2027)

8.4.3.  Europe Nutrigenomics Sales by Countries (2017-2027)

8.4.4.  Europe Nutrigenomics Revenue (Million USD) by Countries (2017-2027)

8.4.5.  Germany

8.4.5.1.    Germany Nutrigenomics Sales and Growth Rate (2017-2027)

8.4.5.2.    Germany Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  UK

8.4.6.1.    UK Nutrigenomics Sales and Growth Rate (2017-2027)

8.4.6.2.    UK Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  France

8.4.7.1.    France Nutrigenomics Sales and Growth Rate (2017-2027)

8.4.7.2.    France Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Russia

8.4.8.1.    Russia Nutrigenomics Sales and Growth Rate (2017-2027)

8.4.8.2.    Russia Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.9.  Italy

8.4.9.1.    Italy Nutrigenomics Sales and Growth Rate (2017-2027)

8.4.9.2.    Italy Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.10.      Rest of Europe

8.4.10.1. Rest of Europe Nutrigenomics Sales and Growth Rate (2017-2027)

8.4.10.2. Rest of Europe Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.       Asia-Pacific

8.5.1.  Asia-Pacific Nutrigenomics Sales and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Nutrigenomics Revenue and Growth Rate (2017-2027)

8.5.3.  Asia-Pacific Nutrigenomics Sales by Countries (2017-2027)

8.5.4.  Asia-Pacific Nutrigenomics Revenue (Million USD) by Countries (2017-2027)

8.5.5.  China

8.5.5.1.    China Nutrigenomics Sales and Growth Rate (2017-2027)

8.5.5.2.    China Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.  Japan

8.5.6.1.    Japan Nutrigenomics Sales and Growth Rate (2017-2027)

8.5.6.2.    Japan Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.3.     

8.5.7.  Korea

8.5.7.1.    Korea Nutrigenomics Sales and Growth Rate (2017-2027)

8.5.7.2.    Korea Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  India

8.5.8.1.    India Nutrigenomics Sales and Growth Rate (2017-2027)

8.5.8.2.    India Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.9.  Southeast Asia

8.5.9.1.    Southeast Asia Nutrigenomics Sales and Growth Rate (2017-2027)

8.5.9.2.    Southeast Asia Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.10.      Rest of Asia-Pacific

8.5.10.1. Rest of Asia-Pacific Nutrigenomics Sales and Growth Rate (2017-2027)

8.5.10.2. Rest of Asia-Pacific Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.       South America

8.6.1.  South America Nutrigenomics Sales and Growth Rate (2017-2027)

8.6.2.  South America Nutrigenomics Revenue and Growth Rate (2017-2027)

8.6.3.  South America Nutrigenomics Sales by Countries (2017-2027)

8.6.4.  South America Nutrigenomics Revenue (Million USD) by Countries (2017-2027)

8.6.5.  Brazil

8.6.5.1.    Brazil Nutrigenomics Sales and Growth Rate (2017-2027)

8.6.5.2.    Brazil Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Argentina

8.6.6.1.    Argentina Nutrigenomics Sales and Growth Rate (2017-2027)

8.6.6.2.    Argentina Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.7.  Columbia

8.6.7.1.    Columbia Nutrigenomics Sales and Growth Rate (2017-2027)

8.6.7.2.    Columbia Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.8.  Rest of South America

8.6.8.1.    Rest of South America Nutrigenomics Sales and Growth Rate (2017-2027)

8.6.8.2.    Rest of South America Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.       Middle East and Africa

8.7.1.  Middle East and Africa Nutrigenomics Sales and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Nutrigenomics Revenue and Growth Rate (2017-2027)

8.7.3.  Middle East and Africa Nutrigenomics Sales by Countries (2017-2027)

8.7.4.  Middle East and Africa Nutrigenomics Revenue (Million USD) by Countries (2017-2027)

8.7.5.  Saudi Arabia

8.7.5.1.    Saudi Arabia Nutrigenomics Sales and Growth Rate (2017-2027)

8.7.5.2.    Saudi Arabia Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  United Arab Emirates

8.7.6.1.    United Arab Emirates Nutrigenomics Sales and Growth Rate (2017-2027)

8.7.6.2.    United Arab Emirates Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  Egypt

8.7.7.1.    Egypt Nutrigenomics Sales and Growth Rate (2017-2027)

8.7.7.2.    Egypt Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  Nigeria

8.7.8.1.    Nigeria Nutrigenomics Sales and Growth Rate (2017-2027)

8.7.8.2.    Nigeria Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  South Africa

8.7.9.1.    South Africa Nutrigenomics Sales and Growth Rate (2017-2027)

8.7.9.2.    South Africa Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.10.      Rest of Middle East and Africa

8.7.10.1. Rest of Middle East and Africa Nutrigenomics Sales and Growth Rate (2017-2027)

8.7.10.2. Rest of Middle East and Africa Nutrigenomics Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.       WellGen Inc.

9.1.1.  Business Overview

9.1.2.  Product Portfolio

9.1.3.  Strategic Developments

9.1.4.  Sales, Revenue and Market Share

9.2.       Metagenics, Inc

9.2.1.  Business Overview

9.2.2.  Product Portfolio

9.2.3.  Strategic Developments

9.2.4.  Sales, Revenue and Market Share

9.3.       Genomix Nutrition, Inc.

9.3.1.  Business Overview

9.3.2.  Product Portfolio

9.3.3.  Strategic Developments

9.3.4.  Sales, Revenue and Market Share

9.4.       Nutrigenomix

9.4.1.  Business Overview

9.4.2.  Product Portfolio

9.4.3.  Strategic Developments

9.4.4.  Sales, Revenue and Market Share

9.5.       NutraGene

9.5.1.  Business Overview

9.5.2.  Product Portfolio

9.5.3.  Strategic Developments

9.5.4.  Sales, Revenue and Market Share

9.6.       XCODE Life Sciences Pvt. Ltd.

9.6.1.  Business Overview

9.6.2.  Product Portfolio

9.6.3.  Strategic Developments

9.6.4.  Sales, Revenue and Market Share

9.7.        Cura Integrative Medicine

9.7.1.  Business Overview

9.7.2.  Product Portfolio

9.7.3.  Strategic Developments

9.7.4.  Sales, Revenue and Market Share

10.   Global Nutrigenomics Market Competition, by Manufacturer

10.1.    Global Nutrigenomics Sales and Market Share by Manufacturer (2017-2017)

10.2.    Global Nutrigenomics Revenue and Market Share by Manufacturer (2017-2017)

10.3.    Global Nutrigenomics Price by Manufacturer (2017-2017)

10.4.    Top 5 Nutrigenomics Manufacturer Market Share

10.5.    Market Competition Trend

11.   Nutrigenomics Market Forecast (2027-2023)

11.1.    Global Nutrigenomics Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

11.2.    Nutrigenomics Market Forecast by Regions (2027-2023)

11.2.1.      North America Nutrigenomics Market Forecast (2027-2023)

11.2.1.1. United States Nutrigenomics Market Forecast (2027-2023)

11.2.1.2. Canada Nutrigenomics Market Forecast (2027-2023)

11.2.1.3. Mexico Nutrigenomics Market Forecast (2027-2023)

11.2.2.      Europe Nutrigenomics Market Forecast (2027-2023)

11.2.2.1. Germany Nutrigenomics Market Forecast (2027-2023)

11.2.2.2. United Kingdom Solid State Drive (SSD)s Market Forecast (2027-2023)

11.2.2.3. France Nutrigenomics Market Forecast (2027-2023)

11.2.2.4. Russia Nutrigenomics Market Forecast (2027-2023)

11.2.2.5. Italy Nutrigenomics Market Forecast (2027-2023)

11.2.2.6. Rest of the Europe Nutrigenomics Market Forecast (2027-2023)

11.2.3.      Asia-Pacific Nutrigenomics Market Forecast (2027-2023)

11.2.3.1. China Nutrigenomics Market Forecast (2027-2023)

11.2.3.2. Japan Nutrigenomics Market Forecast (2027-2023)

11.2.3.3. Korea Nutrigenomics Market Forecast (2027-2023)

11.2.3.4. India Nutrigenomics Market Forecast (2027-2023)

11.2.3.5. Southeast Asia Nutrigenomics Market Forecast (2027-2023)

11.2.3.6. Rest of Asia-Pacific Nutrigenomics Market Forecast (2027-2023)

11.2.4.      South America Nutrigenomics Market Forecast (2027-2023)

11.2.4.1. Brazil Nutrigenomics Market Forecast (2027-2023)

11.2.4.2. Argentina Nutrigenomics Market Forecast (2027-2023)

11.2.4.3. Columbia Nutrigenomics Market Forecast (2027-2023)

11.2.4.4. Rest of South America Nutrigenomics Market Forecast (2027-2023)

11.2.5.      Middle East and Africa Nutrigenomics Market Forecast (2027-2023)

11.2.5.1. Saudi Arabia Nutrigenomics Market Forecast (2027-2023)

11.2.5.2. UAE Nutrigenomics Market Forecast (2027-2023)

11.2.5.3. Egypt Nutrigenomics Market Forecast (2027-2023)

11.2.5.4. Nigeria Nutrigenomics Market Forecast (2027-2023)

11.2.5.5. South Africa Nutrigenomics Market Forecast (2027-2023)

11.2.5.6. Rest of MEA Nutrigenomics Market Forecast (2027-2023)

11.3.    Nutrigenomics Market Forecast by Product (2027-2023)

11.3.1.      Global Nutrigenomics Sales Forecast by Product (2027-2023)

11.3.2.      Global Nutrigenomics Sales Market Share Forecast by Product (2027-2023)

11.4.    Nutrigenomics Market Forecast by Application (2027-2023)

11.4.1.      Global Nutrigenomics Sales Forecast by Application (2027-2023)

11.4.2.      Global Nutrigenomics Sales Market Share Forecast by Application (2027-2023)

11.5.    Nutrigenomics Market Forecast by Techniques (2027-2023)

11.5.1.      Global Nutrigenomics Sales Forecast by Techniques (2027-2023)

11.5.2.      Global Nutrigenomics Sales Market Share Forecast by Techniques (2027-2023)

*You can glance through the list of Tables and Figures when you view the sample copy of Nutrigenomics Market.

 

 

 

 

 

---

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Nutrigenomics Market.

---

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country